Treatt has had another successful half year, and the COVID-19 pandemic has, to date, had no adverse effect on the business. As previously stated, the sharp fall in citrus prices during FY19 has continued into H120, hence H1 revenue is down 5.6% at constant currency. There was good growth in the other parts of the business, with tea and health & wellness as the standout performers. Building work on the new UK site has slowed due to the COVID-19 pandemic, and at this stage guidance is for r
09 Apr 2020
Treatt - Demonstrating its resilience
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Treatt - Demonstrating its resilience
Treatt plc (TET:LON) | 483 12.1 0.5% | Mkt Cap: 295.8m
- Published:
09 Apr 2020 -
Author:
Sara Welford -
Pages:
4
Treatt has had another successful half year, and the COVID-19 pandemic has, to date, had no adverse effect on the business. As previously stated, the sharp fall in citrus prices during FY19 has continued into H120, hence H1 revenue is down 5.6% at constant currency. There was good growth in the other parts of the business, with tea and health & wellness as the standout performers. Building work on the new UK site has slowed due to the COVID-19 pandemic, and at this stage guidance is for r